uMed

📍 Cambridge, United States🗓 Founded 2018👥 88 employees💰 Last funded Mar 2025
Research Services🌐 umed.io
Website LinkedIn
uMed combines RWE with the power of patient generated data to address the evidence gaps in life science research. By leveraging uMed’s ACCESS Research Platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples.
6
Total investors
3
Early stage
2
Mid stage
1
Late stage
2018
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
4
United States
2
Investor activity2015–2025 · investors recorded per year
20151202022023220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in uMed?
uMed has 6 investors on record on gritt.io, including 3 early-stage backers, 2 mid-stage and 1 late-stage investors.
When did uMed last raise funding?
The most recent investment in uMed recorded on gritt.io was in March 2025.
When was uMed founded?
uMed was founded in 2018.
What industry is uMed in?
uMed operates in Research Services. Find similar Research Services investors on gritt.io.
Where is uMed based?
uMed is headquartered in Cambridge, United States.